Emma de Moel - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Emma de Moel

This paper was not found in any repository, but could be made available legally by the author.

2021 Josephine A. M. P. Amkreutz

ORCID

, Emma C. Moel

ORCID

, Lisa Theander, Minna Willim, Lotte Heimans, Jan‐Åke Nilsson, Magnus K. Karlsson, Tom W. J. Huizinga

ORCID

, Kristina E. Åkesson, Lennart T. H. Jacobsson, Cornelia F. Allaart, Carl Turesson

ORCID

ORCID

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis

Upload

This paper is made freely available by the publisher.

2019 Emma C. de Moel

ORCID

, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude

ORCID

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Emma C. de Moel

ORCID

, Veerle F. A. M. Derksen, Leendert A. Trouw, Holger Bang, Gerard Collée, Leroy R. Lard, Sofia Ramiro, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Diane van der Woude

ORCID

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Emma C. de Moel

ORCID

, Elisa A. Rozeman, Ellen H. Kapiteijn, Els M. E. Verdegaal

ORCID

, Annette Grummels, Jaap A. Bakker

ORCID

, Tom W. J. Huizinga, John B. Haanen, René E. M. Toes

ORCID

, Diane van der Woude

ORCID

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

Upload

Missing publications? Search for publications with a matching author name.